MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2022-23)
- Udyam number
- UDYAM-TS-02-0003927
Nasense Labs Private Limited - chemicals and materials in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹135.51 Cr
▲ 17% YoY
Net profit · FY 2025
₹5.7 Cr
Net margin 4.2%
EBITDA · FY 2025
₹18.64 Cr
EBITDA margin 13.8%
Authorised capital
₹24 Cr
Registered with MCA
Paid-up capital
₹23.57 Cr
Issued & subscribed
Open charges
₹78.17 Cr
Satisfied ₹54.65 Cr
Company age
31 yrs
Est. 1995
Employees · EPFO
81
Provident fund records
About Nasense Labs Private Limited
Data last updated:
Nasense Labs Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the specialty chemicals segment of the chemicals and materials sector. It was incorporated on 24 March 1995 and has been in existence for over 31 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24231TG1995PTC019809. Its GSTIN is 36AAACU6806D1ZJ (Telangana). The company holds 3 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹24 Cr and a paid-up capital of ₹23.57 Cr. It was formerly known as Usp Organics Private Limited and Usp Scientifics Private Limited. It is led by directors including Goutam Gottumukkala (Managing Director) and Arjun Gottumukkala.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot Nos. 24 & 25 S. V. Co – Operative Indl Estate Jeedimetla Quthubullapur (M), Hyderabad, Telangana, India – 500055.
As per the financials filed for FY 2025, the company reported a revenue of ₹135.51 Cr, a growth of 17% compared to the previous year. For the same year it recorded a net profit of ₹5.7 Cr (net margin 4.2%) and EBITDA of ₹18.64 Cr (EBITDA margin 13.8%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years.
The company has about 81 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Nasense Labs. As per MCA filings, the company has open charges of ₹78.17 Cr and satisfied charges of ₹54.65 Cr on record. Court records list 34 cases involving the company, including 2 filed by the company and 32 filed against it; 1 case is pending. The company has 6 deals on record (3 funding rounds, 2 secondary share transfers, 1 rights issue), with disclosed funding of ₹18.98 Cr; the latest was in August 2021. Its 9 peer companies in the Chemicals industry (Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 5 smaller; the largest is Prolife Bio-Chemical Industries Private Limited with revenue of ₹141.84 Cr.
Nasense Labs Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0003927). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website nasense.com.
Company details
CIN U24231TG1995PTC019809
Registration Number 019809
Incorporation Date 24 March 1995
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-TS-02-0003927
Name history
Nasense Labs has undergone 2 name changes throughout its history. The company was previously known as Usp Organics Private Limited, and Usp Scientifics Private Limited. The current legal name is Nasense Labs Private Limited.
| Company Name | Status |
|---|---|
| Nasense Labs Private Limited | Current |
| Usp Organics Private Limited | Previous |
| Usp Scientifics Private Limited | Previous |
CIN history
Nasense Labs has one previous CIN (Corporate Identification Number): U24231AP1995PTC019809. The current CIN is U24231TG1995PTC019809, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24231TG1995PTC019809 | Current |
| U24231AP1995PTC019809 | Previous |
Key People
Goutam Gottumukkala Managing Director Prasad Jakkaraju Nominee Director Arjun Gottumukkala Director Recognitions & Rankings of Nasense Labs
Contact details
Nasense Labs Private Limited's registered office is in Hyderabad, Telangana. Its website is nasense.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot Nos. 24 & 25 S. V. Co – Operative Indl Estate Jeedimetla Quthubullapur (M), Hyderabad, Telangana, India – 500055
- IndustryChemicals and Materials, Specialty Chemicals
To see the full contact details of Nasense Labs Private Limited, buy the company report.
Comprehensive company report
Nasense Labs Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Nasense Labs operates one associated brand: Nasense Labs. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures fine chemicals, pyridine derivatives, and pharmaceutical intermediates for industries. | nasense.com |
Business activity
The main business activity of Nasense Labs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Nasense Labs Private Limited, buy the company report.
Financials of Nasense Labs Private Limited
FY 2024 filings availableNasense Labs Private Limited reported revenue of ₹135.51 Cr (up 17% YoY) for FY 2025.
Revenue · FY 2025
₹135.51 Cr ▲ 17%
Net profit · FY 2025
₹5.7 Cr margin 4.2%
EBITDA · FY 2025
₹18.64 Cr margin 13.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 17%
3 years · compounded
▲ 2%
EBITDA CAGR growth
1 year
▲ 51%
3 years · compounded
▲ 95%
5 years · compounded
▲ 5%
Revenue has grown at a compounded annual rate (CAGR) of 2% over three years, including 17% growth in the latest year. EBITDA rose 51% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹18.64 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.7 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 13.8% | ||||
| Net Profit Margin | 4.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nasense Labs Private Limited, buy the company report.
Board of directors of Nasense Labs Private Limited
Nasense Labs has 4 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prasad Jakkaraju Also directs: Nacl Spec-Chem Limited | Nominee Director | 15 Feb 2022 | 4 Years 8 Months | Current |
| Arjun Gottumukkala | Director | 30 Sep 2022 | 4 Years 0 Months | Current |
| Goutam Gottumukkala | Managing Director | 02 Apr 2009 | 17 Years 6 Months | Current |
| Venkata Satya Samba Siva Rao Mantripragada Also directs: KLR Products Limited | Nominee Director | 15 Feb 2022 | 4 Years 8 Months | Current |
Peer comparison
Nasense Labs Private Limited is compared with the 9 companies closest to it by revenue in the Chemicals industry (Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Prolife Bio-Chemical Industries Private Limited | ₹141.84 Cr (FY 2025) | 22.0% | Ahmedabad, Gujarat, India | |||
| Imerys Vizag Private Limited | ₹138.49 Cr (FY 2025) | 44.0% | Anakapalle, Andhra Pradesh, India | |||
| Corvine Chemicals and Pharmaceuticals Private Limited | ₹136.26 Cr (FY 2025) | 10.0% | Bidar, Karnataka, India | |||
| Mody Chemi Pharma Limited | ₹136.07 Cr (FY 2025) | -11.0% | Mumbai, Maharashtra, India | |||
| Nasense Labs Private Limitedthis company | ₹135.51 Cr (FY 2025) | ₹5.7 Cr | 4.2% | 17.0% | 81 | Hyderabad, Telangana, India |
| Katra Phytochem (India) Private Limited | ₹134.65 Cr (FY 2024) | 6.0% | Bangalore, Karnataka, India | |||
| Melog Speciality Chemicals Private Limited | ₹134.59 Cr (FY 2025) | -3.0% | Mumbai, Maharashtra, India | |||
| Chemfield Cellulose Private Limited | ₹134.22 Cr (FY 2025) | 27.0% | Nagpur, Maharashtra, India | |||
| Surabhi Industries (India) Private Limited | ₹133.75 Cr (FY 2024) | -37.0% | Hyderabad, Telangana, India | |||
| Navdeep Chemicals Private Limited | ₹133.57 Cr (FY 2025) | 7.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Nasense Labs Private Limited, buy the company report.
Auditor
Nasense Labs Private Limited is audited by K.R.BAPUJI & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| K.R.BAPUJI & CO | FY 2023 | 000395S |
Shareholding
The shareholding of Nasense Labs Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Nasense Labs Private Limited, buy the company report.
Charges & borrowings
Open charges
₹78.17 Cr
Satisfied charges
₹54.65 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 07 Mar 2025 | 101084502 | Others | ₹6.38 Cr | Open | |
| 28 Nov 2020 | 100398514 | Others | ₹5.57 Cr | Open | |
| 13 Jun 2015 | 10587845 | Others | ₹66.22 Cr | Open | |
| 19 Sep 2020 | 100385732 | Others | ₹1.91 Cr | Satisfied | |
| 07 May 2020 | 100386535 | Others | ₹2.6 Cr | Satisfied |
To see the full charge records of Nasense Labs Private Limited, buy the company report.
Total charge records: 14 View all charges
Deals & funding
Nasense Labs Private Limited has 6 deals on record (3 funding rounds, 2 secondary share transfers, 1 rights issue), with disclosed funding of ₹18.98 Cr; the latest was in August 2021.
Total deals
6
Funding rounds
3
Secondary share transfers
2
Rights issue
1
Disclosed funding
₹18.98 Cr
Deals on record (5 of 6)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Aug 2021 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: an individual |
| Jun 2021 | Secondary share transfer | Undisclosed | Buyer: 2 individuals Seller: 4 individuals |
| Jun 2018 | Rights issue | ₹12.37 Cr | Investors: Nacl Industries Limited , 3 individuals |
| Oct 2013 | Funding round | ₹5.52 Cr | Investors: Nacl Industries Limited , 3 individuals |
| Oct 2010 | Funding round | ₹7.02 Cr | Investors: Nacl Industries Limited , 3 individuals |
To see the full deal history of Nasense Labs Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Nasense Labs Private Limited has 34 court cases on record: 2 filed by Nasense Labs, 32 filed against it. 1 case is pending and 33 are disposed.
Total cases
34
Filed by the company
2
Filed against the company
32
Pending
1
Disposed
33
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 31 | 31 | 0 |
| High courts | 3 | 1 | 1 |
Cases on record (5 of 34)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Cases) | Filed against the company by Resonance Specialties Ltd Through Authorized Representative Vaibhavi Rajeshirke | Disposed |
| District court, Medchal Malkajgiri, Telangana | Execution petition | Filed against the company by M/S India Infoline Finance Ltd Rep. by Jeevan Kumar Dosala | Disposed |
| District court, Hyderabad Central, Telangana | Court case (STC - NI) | Filed against the company by M/S. Reliance Commercial Finance Ltd, Rep by Its Deputy Manager Javed Hussain | Disposed |
| High Court, TAMIL NADU | Court case (CRL OP) | Filed by the company against Balmer Lawrie and Co.Ltd., Rep and 2 others | Disposed |
| District court, Hyderabad Central, Telangana | Criminal complaint | Filed against the company by M/S Bajaj Finance Limited., Rep.By M. Ravind | Disposed |
To see the full case history of Nasense Labs Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Nasense Labs Private Limited was last rated by Acuite on 03 Aug 2026.
| Rating agency | Rated on | Rating |
|---|---|---|
| Acuite | 03 Aug 2026 |
To see the full credit ratings and regulatory alerts of Nasense Labs Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nasense Labs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Nasense Labs has 1 associated company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
1
Associated companies
Employees & EPFO
Nasense Labs Private Limited has a workforce of 81 employees on its EPFO records as of Mar 27, 2024, across 1 active EPFO establishment.
Employee count
81
Active EPFO establishments
1
Employee growth
-3.57%
GST
Nasense Labs has 3 GST registrations: 1 active and 2 cancelled or inactive.
Total GSTINs
3
Active
1
Cancelled / inactive
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAACU6806D1ZJ | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Nasense Labs Private Limited, buy the company report.
Recent activity
Nasense Labs Private Limited has 14 board changes on record since 2007: 4 appointments and 10 cessations. The latest: Arjun Gottumukkala was appointed as Director on 30 Sep 2022.
Charges
A charge with Others amounted to Rs. 6.38 Cr with Charge ID 101084502 was registered on 07 Mar 2025.
AGM
Nasense Labs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Nasense Labs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Charges
A charge with Others of Rs. 66.22 Cr registered on 13 Jun 2015 with Charge ID 10587845 was modified on 22 Jun 2023.
Charges
A charge registered on 27 Jun 2016 via Charge ID 100037567 with Others was fully satisfied on 30 Nov 2022.
Appointed
Arjun Gottumukkala was appointed as Director.
Ceased
Uma Gottumukkala ceased to be Whole-Time Director.
Charges
A charge registered on 19 Sep 2020 via Charge ID 100385732 with Others was fully satisfied on 22 Jul 2022.
Charges
A charge registered on 07 May 2020 via Charge ID 100386535 with Others was fully satisfied on 22 Jul 2022.
Charges
A charge registered on 18 Sep 2018 via Charge ID 100205467 with Others was fully satisfied on 12 Jul 2022.
Charges
A charge registered on 01 Jan 2018 via Charge ID 100150030 with Others was fully satisfied on 12 Jul 2022.
Charges
A charge registered on 24 Jul 2017 via Charge ID 100115446 with Others was fully satisfied on 12 Jul 2022.
32 earlier events are in the company report.
Frequently asked questions
Nasense Labs is an active private limited company based in Hyderabad, Telangana, India. The company works in specialty chemicals, within the chemicals and materials industry. It was incorporated on 24 March 1995 (31+ years old) and is registered under CIN U24231TG1995PTC019809.
Nasense Labs has 4 current directors:
- Goutam Gottumukkala - Managing Director
- Prasad Jakkaraju - Nominee Director
- Arjun Gottumukkala - Director
- Venkata Satya Samba Siva Rao Mantripragada - Nominee Director
The latest financial statements of Nasense Labs on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Nasense Labs is 36AAACU6806D1ZJ, registered in Telangana. The company has 3 GST registrations in all, of which 1 is active and 2 are cancelled or inactive.
The CIN (Corporate Identification Number) of Nasense Labs is U24231TG1995PTC019809. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nasense Labs has 34 court cases on record: 2 filed by the company and 32 filed against it. 1 is pending. Most are in the district courts.
Nasense Labs was incorporated on 24 March 1995, making it 31+ years old. It is registered with the Registrar of Companies, Hyderabad.
Nasense Labs has 6 deals on record (3 funding rounds, 2 secondary share transfers, 1 rights issue), with disclosed funding of ₹18.98 Cr; the latest was in August 2021.
The peers of Nasense Labs by revenue are Prolife Bio-Chemical Industries Private Limited, Imerys Vizag Private Limited, Corvine Chemicals and Pharmaceuticals Private Limited, Mody Chemi Pharma Limited, Katra Phytochem (India) Private Limited and 4 more, all in the Chemicals industry (Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Arjun Gottumukkala was appointed as Director on 30 Sep 2022. Uma Gottumukkala ceased to be Whole-Time Director on 30 Sep 2022. Harish Chandra Bijlwan ceased to be Nominee Director on 15 Feb 2022. Nasense Labs has 14 board changes on record in total.
Yes, Nasense Labs is registered as a medium enterprise under Udyam registration (number: UDYAM-TS-02-0003927).